ArticleNeuropsychiatric disease and treatment2025
Residual Inflammatory Risk Is Associated with Cognitive Impairment After Acute Ischemic Stroke.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Acute ischemic stroke (AIS) may lead to varying degrees of cognitive impairment, while the inflammatory response plays a significant role in this process. This study aims to examine the relationship between residual inflammation risk (RIR) and the development of post-stroke cognitive impairment (PSCI) in patients with acute ischemic stroke. Methods: This prospective cohort study enrolled a total of 172 patients diagnosed with AIS over the study period from January 2024 to December 2024. They were divided into four groups: RIR only [low-density lipoprotein cholesterol (LDL-C) < 2.6 mmol/L and high-sensitivity CRP (hsCRP) ≥ 2 mg/L], residual cholesterol risk (RCR) only (LDL-C ≥ 2.6 mmol/L and hsCRP < 2 mg/L), both risk or residual cholesterol and inflammatory risk (RCIR) (LDL-C ≥ 2.6 mmol/L and hsCRP ≥ 2 mg/L), and neither risk (LDL-C < 2.6mmol/L and hsCRP < 2 mg/L). PSCI is defined as a Montreal Cognitive Assessment (MoCA) score below 22 at 6 months after stroke. The final analysis included 172 patients who completed the follow-up. The association between RIR and PSCI was analyzed by multivariable logistic regression analyses. Results: Among the 172 enrolled patients, 58 (33.7%) developed PSCI. The proportion of patients with neither risk, RIR, RCR, and RCIR was 23.8% (n=41),18.6% (n=32), 32.0% (n=55) and 25.6% (n=44), respectively. Compared to those without PSCI, patients with PSCI had a higher prevalence of hyperlipidemia ( Conclusion: This study presents what is, to our knowledge, the first evidence that RIR is associated with PSCI among acute ischemic stroke patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.